| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Arena Pharmaceuticals (NASDAQ:ARNA) reported its Q4 earnings results on Wednesday, February 23, 2022 at 04:00 PM.
Here's what investors need to know about the announcement.
Arena Pharmaceuticals missed estimated earnings by 12.39%, reporting an EPS of $-2.54 versus an estimate of $-2.26.
Revenue was up $17.00 thousand from the same period last year.
Last quarter the company missed on EPS by $0.68 which was followed by a 3.32% drop in the share price the next day.
Here's a look at Arena Pharmaceuticals's past performance:
| Quarter | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|
| EPS Estimate | -2.53 | -2.19 | -2.16 | -1.85 |
| EPS Actual | -3.21 | -2.40 | -1.98 | -2.10 |
| Revenue Estimate | 680.00K | 900.00K | 570.00K | 560.00K |
| Revenue Actual | 0 | 0 | 0 | 37.00K |
To track all upcoming earnings announcements, click to use Benzinga Earnings Calendar.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: ARNA
